HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlson, S. A. Articles by Fisher, R. A. Search for Related Content PubMed PubMed Citation Articles by Carlson, S. A. Articles by Fisher, R. A. Social Bookmarking                      What's this?

Volume 271, Number 38, Issue of September 20, 1996 pp. 23146-23153
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

The Third Intracellular Domain of the Platelet-activating Factor Receptor Is a Critical Determinant in Receptor Coupling to Phosphoinositide Phospholipase C-activating G Proteins
STUDIES USING INTRACELLULAR DOMAIN MINIGENES AND RECEPTOR CHIMERAS

(Received for publication, April 8, 1996, and in revised form, June 26, 1996)

From the Department of Pharmacology, University of Iowa College of Medicine, Iowa City, Iowa 52242

Platelet activating factor (PAF) is a potent phospholipid mediator which elicits a diverse array of biological actions by interacting with G protein-coupled PAF receptors (PAFR). Binding of PAF to PAFRs leads to activation of G protein(s) that stimulate phosphoinositide phospholipase C and subsequent intracellular signaling responses. To identify the potential role of intracellular domains of the rat PAFR (rPAFR) in signaling, we examined effects of transfecting minigenes encompassing rPAFR intracellular domains 1 (1i), 2 (2i), and 3 (3i) on inositol phosphate (IP) production mediated by the co-transfected rPAFR cDNA. Although transfection of the rPAFR1i and rPAFR2i minigenes had no effects on PAF-stimulated signaling, transfection of the rPAFR3i minigene inhibited PAF-stimulated IP production by approximately 50% compared to controls. The rPAFR3i domain did not inhibit IP production mediated by the multifunctional rat pituitary adenylate cyclase-activating polypeptide receptor (rPACAPR), demonstrating the specificity of the competition by the rPAFR3i domain. In further experiments, the rPAFR3i domain was engineered onto the homologous domain of a monofunctional transmembrane variant of the rPACAPR (rPACAPR₂) that activates only adenylyl cyclase. The rPACAPR₂/rPAFR3i chimera responded to PACAP with increases in IP production which were attenuated nearly completely in cells cotransfected with the rPAFR3i domain. In contrast, PACAP had no effects on IP production in a receptor chimera expressing a mutated form of the rPAFR3i domain (rPACAPR₂/rPAFR3i_mut). These results demonstrate the ability of the rPAFR3i domain to confer a phospholipase C-signaling phenotype to a receptor deficient in this activity and show that this activity is specific for the engineered rPAFR3i domain. These results suggest that the third intracellular loop of the rPAFR is a primary determinant in its coupling to phosphoinositide phospholipase C-activating G proteins, providing the first insight into the molecular basis of interaction of PAFRs with signal-transducing G proteins.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Leanos-Miranda, A. Ulloa-Aguirre, T. H. Ji, J. A. Janovick, and P. M. Conn Dominant-Negative Action of Disease-Causing Gonadotropin-Releasing Hormone Receptor (GnRHR) Mutants: A Trait That Potentially Coevolved with Decreased Plasma Membrane Expression of GnRHR in Humans J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3360 - 3367. [Abstract] [Full Text] [PDF]

				I. GOUNI-BERTHOLD and A. SACHINIDIS Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells? FASEB J, October 1, 2002; 16(12): 1477 - 1487. [Abstract] [Full Text] [PDF]

				J. Ahamed and H. Ali Distinct Roles of Receptor Phosphorylation, G Protein Usage, and Mitogen-activated Protein Kinase Activation on Platelet Activating Factor-induced Leukotriene C4 Generation and Chemokine Production J. Biol. Chem., June 14, 2002; 277(25): 22685 - 22691. [Abstract] [Full Text] [PDF]

				A. Gilchrist, A. Li, and H. E Hamm G{alpha} COOH-Terminal Minigene Vectors Dissect Heterotrimeric G Protein Signaling Sci. Signal., February 5, 2002; 2002(118): pl1 - pl1. [Abstract] [Full Text] [PDF]

				B. O. Ibe, F. C. Sander, and J. U. Raj Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1168 - H1176. [Abstract] [Full Text] [PDF]

				H. M. Miettinen, J. M. Gripentrog, M. M. Mason, and A. J. Jesaitis Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein J. Biol. Chem., September 24, 1999; 274(39): 27934 - 27942. [Abstract] [Full Text] [PDF]

				A. Gilchrist, M. Bunemann, A. Li, M. M. Hosey, and H. E. Hamm A Dominant-Negative Strategy for Studying Roles of G Proteins in Vivo J. Biol. Chem., March 5, 1999; 274(10): 6610 - 6616. [Abstract] [Full Text] [PDF]

				S. A. Carlson and B. D. Jones Inhibition of Salmonella typhimurium Invasion by Host Cell Expression of Secreted Bacterial Invasion Proteins Infect. Immun., November 1, 1998; 66(11): 5295 - 5300. [Abstract] [Full Text] [PDF]

				Y. Djellas, K. Antonakis, and G. C. Le Breton A molecular mechanism for signaling between seven-transmembrane receptors: evidence for a redistribution of G proteins PNAS, September 1, 1998; 95(18): 10944 - 10948. [Abstract] [Full Text] [PDF]

				L-D. Wang, M. Hoeltzel, I. Gantz, R. Hunter, and J. Del Valle Characterization of the Histamine H2 Receptor Structural Components Involved in Dual Signaling J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 573 - 578. [Abstract] [Full Text]

				S. A. Carlson, T. K. Chatterjee, K. P. Murphy, and R. A. Fisher Mutation of a Putative Amphipathic alpha -Helix in the Third Intracellular Domain of the Platelet-Activating Factor Receptor Disrupts Receptor/G Protein Coupling and Signaling Mol. Pharmacol., March 1, 1998; 53(3): 451 - 458. [Abstract] [Full Text]

				D. P. Hajjar and M. E. Haberland Lipoprotein Trafficking in Vascular Cells. MOLECULAR TROJAN HORSES AND CELLULAR SABOTEURS J. Biol. Chem., September 12, 1997; 272(37): 22975 - 22978. [Full Text] [PDF]

				R. Grosse, T. Schöneberg, G. Schultz, and T. Gudermann Inhibition of Gonadotropin-Releasing Hormone Receptor Signaling by Expression of a Splice Variant of the Human Receptor Mol. Endocrinol., August 1, 1997; 11(9): 1305 - 1318. [Abstract] [Full Text]

				T. K. Chatterjee, A. K. Eapen, and R. A. Fisher A Truncated Form of RGS3 Negatively Regulates G Protein-coupled Receptor Stimulation of Adenylyl Cyclase and Phosphoinositide Phospholipase C J. Biol. Chem., June 13, 1997; 272(24): 15481 - 15487. [Abstract] [Full Text] [PDF]